BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The landscape of biologics discovery is rapidly evolving\, dri
 ven by breakthroughs in AI\, an influx of high-quality datasets\, and reg
 ulatory momentum supporting in silico approaches. As industry leaders loo
 k to streamline R and D and de-risk development\, there is a critical nee
 d for cutting-edge tools in modeling\, characterization\, screening\, and
  developability.\n\nReturning to Boston this fall at this opportune momen
 t\, the 10th anniversary of the CDD for Biologics Summit will unite 50+ d
 ecision-makers and industry experts from pharma and biotech to share thei
 r unfiltered lessons learned from validating and training computational m
 odels to streamline novel target validation\, enhance biologics design an
 d empower developability predictions.\n\nThis is the go-to forum for inno
 vators across pharma and biotech to showcase current pipeline development
 s that can enable faster\, smarter\, and more scalable therapeutic design
 .\n\nDiving into the latest industry applications of computational models
 \, including physics-based\, generative AI\, and de novo design across mu
 ltiple large molecules\, including peptides\, ADCs\, bispecific T-cell en
 gagers\, multi-specifics\, vaccines\, and more.\n\nURLs:Tickets: https://
 go.evvnt.com/3115184-1?pid=185Brochure: https://go.evvnt.com/3115184-3?pi
 d=185\n\nTime: 8:30 AM - 5:00 PM\n\nPrices:Conference + Pre-Conference AI
  Validation Workshop Day - Industry Pricing: USD 3297.00\,Conference + Pr
 e-Conference AI Validation Workshop Day - Discounted Pricing: USD 2697.00
 \,Conference + Pre-Conference AI Validation Workshop Day: USD 4197.00\,Co
 nference Only - Industry Pricing: USD 2499.00\,Conference Only - Discount
 ed Pricing: USD 2099.00\,Conference Only - Service and Solution Provider 
 Pricing: USD 3199.00\n\nSpeakers: Abhinav Gupta\, Senior Scientist - Arti
 ficial Intelligence Innovation for Antibody\, Sanofi\, Andrew Wollacott\,
  Sr. Director\, Research\, Visterra\, Gabor Oroszlan\, In Silico Lead\, P
 roject Manager\, Senior Scientist\, VRG Therapeutics\, Gopal Karemore\, G
 lobal Quantum Lead in Healthcare and Life Sciences\, IBM\, James Bowman\,
  Senior Investigator and Director - Protein Engineeering\, AI Proteins\, 
 Jenna Caldwell\, Associate Principal Scientist\, AstraZeneca\, Jinbo Xu\,
  Professor\, Toyota Technological Institute at Chicago\, Jing Wang\, Dire
 ctor\, Eli Lilly and Co.\, Joel Karpiak\, Senior Director\, Head of Prote
 in Design and Informatics\, GlaxoSmithKline\, Kannan Sankar\, Senior Expe
 rt - Data Science and Bioinformatics\, Novartis\, Mark Aquino\, Principal
  Data Scientist II\, AbbVie\, Natnael Hamda\, Associate Director AI ML Re
 search Scientist (Early Drug Discovery)\, Astellas Pharma\, Neeraj Agrawa
 l\, Director\, Attribute Sciences\, Process Development\, Amgen\, Norbert
  Furtmann\, Head of AI Innovation - Large Molecules Research\, Sanofi\, R
 adoslav Enchev\, Group Leader\, The Francis Crick Institute\, Ryan Emerso
 n\, SVP\, Data Science and GM\, Platform Solutions\, A-Alpha Bio Inc.\, S
 hipra Malhotra\, Senior Scientist - Biologics\, Computational and Machine
  Learning\, Takeda Pharmaceutical\, Talip Uçar\, Senior Director\, AI Res
 earch\, AstraZeneca\, Yao Fan\, Director - Protein Design and Optimizatio
 n\, Tectonic Therapeutic\n
DTEND:20251016T170000
DTSTAMP:20260512T214305Z
DTSTART:20251014T083000
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, Massach
 usetts\, 02116\,
SEQUENCE:0
SUMMARY:The landscape of biologics discovery is rapidly evolving\, driven 
 by breakthroughs in AI\, an influx of high-quality datasets\, and regulat
 ory momentu...
UID:6176914b-e934-4fe1-88cb-f18c202dd205
END:VEVENT
END:VCALENDAR